New study shows brain waves can be manipulated during REM sleep

Brain waves can be manipulated whilst in rapid eye movement (REM) sleep, a sleep stage associated with memory and cognition, a new study from the University of Surrey finds.

MaxCyte and Kamau Therapeutics sign platform license agreement

Kamau’s lead investigational programme, nula-cel, which is based on HDR editing, is currently in clinical development for sickle cell disease. Credit: Babul Hosen /Shutterstock. MaxCyte,

September 17, 2024

Axonics appoints Kari Keese to CFO post as Dan Dearen retires

Name: Kari Keese New title: CFO, Axonics Previous title: Vice president of finance and accounting, Axonics Optional Caption Retrieved from LinkedIn on August 22, 2023

August 22, 2023

FDA OKs Subcutaneous Daratumumab Plus VRd for Myeloma

The FDA approved subcutaneous daratumumab-hyaluronidase (Darzalex Faspro) in combination with bortezomib (Velcade), lenalidomide (Revlimid), and dexamethasone (VRd) for induction and consolidation in patients with newly

August 1, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.